Natera Inc
Change company Symbol lookup
Select an option...
NTRA Natera Inc
ADPT Adaptive Biotechnologies Corp
TDOC Teladoc Health Inc
SPNE SeaSpine Holdings Corp
GBT Global Blood Therapeutics Inc
NYMT New York Mortgage Trust Inc
HY Hyster-Yale Materials Handling Inc
NTES NetEase Inc
EV Eaton Vance Corp
IPG Interpublic Group of Companies Inc
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Natera, Inc. is a diagnostics company. The Company is engaged in the discovery, development and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Horizon Carrier Screening to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children; Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle to select embryos with the probability of becoming healthy children; Anora Products of Conception test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing, to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid in a pregnant mother's blood and a blood sample from the alleged father(s).

Price
Delayed
$35.23
Day's Change
0.22 (0.63%)
Bid
--
Ask
--
B/A Size
--
Day's High
35.87
Day's Low
35.15
Volume
(Light)

Today's volume of 113,736 shares is on pace to be much lighter than NTRA's 10-day average volume of 555,734 shares.

113,736

Nvidia target price lifted to Street-high $315 at Jefferies

8:03 am ET February 12, 2020 (MarketWatch)
Print

Nvidia Corp. shares (NVDA) are up 1% in premarket trading Wednesday after Jefferies analyst Mark Lipacis lifted his price target to $315, the highest target listed on FactSet, ahead of the company's Thursday afternoon earnings report (http://www.marketwatch.com/story/nvidia-earnings-a-return-to-revenue-growth-expected-after-a-tough-year-2020-02-07). His prior target price was $255. "We expect Nvidia to report positive trends in its [data-center] business," he wrote, as cloud players Amazon.com Inc. (AMZN), Microsoft Corp. (MSFT), and Facebook Inc. (FB) all reported sequential growth in capital spending for the fourth quarter. "This is consistent with Nvidia's commentary at CES suggesting strength in data-center revenues in 4Q19 and 1Q20," Lipacis wrote. Another target hike came from Susquehanna analyst Christopher Rolland, who raised his price target to $310 from $285, with his new target now the second highest listed on FactSet. "While Intel was cautious in its data-center forecast for the rest of 2020, we expect Nvidia to release new data-center GPUs in 2020 (likely at GTC) that should reaccelerate growth in this segment upon launch," Rolland wrote. Shares have added 28% over the past three months, as the S&P 500 has climbed 8.6%.

-Emily Bary; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

February 12, 2020 08:03 ET (13:03 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.